(Q33395909)

English

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

thrombocytopenia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

object named as

Anders Hviid

7

0 references

6

object named as

Jan Bonhoeffer

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

object named as

Nick Andrews

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

object named as

Julia Stowe

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Elizabeth Miller

3

object named as

Elizabeth Miller

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Henrik Svanström

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kari Johansen

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

VAESCO consortium

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

23 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3042-3046

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A population-based study of measles, mumps, and rubella vaccination and autism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

No evidence of an association between MMR vaccine and gait disturbance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

MMR Vaccination and Febrile Seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Global Vaccine Safety DataNet meeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Postlicensure epidemiology of childhood vaccination: the Danish experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Idiopathic thrombocytopenic purpura and MMR vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

The methodology of self-controlled case series studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.009

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.06.009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33395909&oldid=1536419973"